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Outline of the thesis 
This PhD thesis stems from a project developed at the Center for Advanced Biomaterials for 
Health Care/CRIB Istituto Italiano di Tecnologia in Naples (Italy). The aim of the project is to 
enhance the ability of bioactive polymeric matrices to guide regeneration through a spatial and 
temporal control of angiogenesis. In this context I was mainly focused on studying the performance 
of engineered constructs from a biological standpoint. I was also involved in multidisciplinary 
activities including scaffold, biomaterial and nanocarrier design and fabrication.  
Aiming to guide angiogenesis in a space and time controlled fashion we produced scaffolds 
with controlled porosity suitable to be loaded with vascular growth factors in order to generate a 
biochemical gradient. To this purpose the constructs were fabricated using two different assembly 
techniques: the random one, which implies an uncontrolled porosity, and the ordered one, which 
allows to control porosity features. Afterwards, I investigated the interplay between the scaffold and 
the cells, as well as the host tissue, after implantation. Several biological processes are mediated by 
biochemical signals, or rather by gradients of these signals, which precise regulation is essential for 
the physiological function of tissues and organs. These gradients, besides the direction also affect 
the rate of cellular invasion as well as the onset of the vascular network. A number of studies show 
that endothelial cells are particularly influenced by extracellular matrix topography.  
Therefore, we decided to investigate if these signals are able to guide sprouting angiogenesis 
in a space and time controlled manner without the use of growth factors. To this aim we used a 
photoswitch-based strategy to modify the biomaterial surface, through a reversible photochemical 
technique, in order to resemble physiological dynamic signals. This part of the thesis project was 
developed through an internal collaboration within the IIT@CRIB with Dr. Silvia Cavalli and Dr. 
Chiara Fedele. 
Finally, since in the past I was involved in studies focused on the therapeutic use of Carbon 
Monoxide (CO) to restore organ function after ischemia/reperfusion injury, I hypothesized that the 
advantages related to the use of polymer nanocarriers may contribute to solve the open challenges 
related to the use of this gas in the clinical practice. These issues are mostly related to the 
administration of CO, specifically to the possibility to get therapeutic concentrations of 
carboxyhaemoglobin in the blood without inducing toxicity.  
Thus, in order to expand my skills, I spent few months at the Center for Life Sciences of 
Beth Israel Deaconess Medical Center at Harvard Medical School (Boston, MA, USA) where I had 
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the possibility to work in a very stimulating environment under the supervision of Prof. L. E. 
Otterbein the key scientist exploring the therapeutic properties of CO. 
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Chapter 1 
 
 
  Introduction 
 
 
 
1.1.1 Tissue engineering: an overview 
The partial or total loss of organs and tissues is a major cause of hospitalization in the world 
(1). Despite the progress made in the field of regenerative medicine, transplantation still remains the 
only option for several degenerative diseases when a substitutive therapy is not available (2).  
However, it still suffers from a number of limitations that reduce its success. First of all, the 
shortage of organ donors, and then the need of a lifelong immunosuppressive therapy, the risk of 
infection at the graft site and other complications such as haemorrhages, fistulas, thrombosis and 
rejection. All these hindrances have led to the development of a new science: tissue engineering 
(TE), that has quickly become a key research area in the field of regenerative medicine (1-3).  
TE is a multidisciplinary science that includes the principles of chemistry, biochemistry, 
medicine, engineering and physics, aiming to provide engineered tissues to restore the lost function 
of damaged tissues and organs (4).  
This discipline combines scaffolds, cells and biologically active molecules to build 
functional tissues. The ability of an engineered construct to resemble the structural and functional 
properties of the damaged tissue is of basic importance to determine the success or the failure of its 
implantation in the host (5). 
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1.1.2 Cell-material interaction  
Cells are the “building blocks” of all tissues, which are the basic functional units of the 
body. However, cells are unable to accomplish their function if the surrounding microenvironment 
is inadequate (6). Tissues, indeed, are made-up of two basic components: the cells and the 
extracellular matrix (ECM). The latter plays a key role in providing mechanical support to the cells 
but also including signal molecules which are critical for cell function.  
By understanding how cells respond to these signals, interact with the surrounding 
microenvironment and organize themselves into tissues and organs, researchers worldwide are 
becoming able to direct cell fate and to restore the original function of damaged tissues, even 
creating new ones. In order to design a novel biomaterial, one of the most important features to 
consider is the so called cell-material interaction, that is the potential interplay between the material 
surface and the cell.  
The biochemical and biophysical characteristics of a biomaterial, indeed, directly influence 
cell behaviour, for example by triggering specific events such as cell adhesion, migration, 
proliferation and differentiation (7). The interaction of biological systems with synthetic material 
surfaces is, therefore, a critical issue for biological applications of implantable devices and 
engineered tissues (8).  
To collect reliable data, the main challenge is the design and the development of a surface 
able to interact with both biomolecules and cells without altering cell function and phenotype (9). 
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Figure1. The image shows the influence of ECM signals in the induction of critical events such as 
cell proliferation, migration and differentiation (Francisco M. et al, Human gene therapy methods, 
2013; 24:160-170). 
 
1.1.3 Biomaterial properties 
A biomaterial is a natural or synthetic material able to be used for biomedical applications. 
There are several classes of biomaterials ranging from organic polymers to metals and glass (10). 
All of them have to fulfil essential requirements in terms of biocompatibility, biodegradability and 
functionality.  
More in details, the first feature is the ability of the material to integrate with the host tissue 
without adverse effects (rejection, inflammation or toxicity), the second is the ability to be degraded 
through the enzymatic reactions that take place in the body, while the third refers to the physical 
and mechanical properties that devices and constructs should have in order to replicate the function 
of the damaged tissue.  
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A key point for many biomaterial applications is the interplay between the material and the 
biological environment after implantation, in particular at tissue/material interface. (5). Synthetic 
biodegradable polymers approved by the Food and Drug Administration are currently chosen by 
several research groups as scaffolding polymers. However, they have a main drawback consisting in 
the lack of specific cellular signals.  
The most widely used synthetic polymers are biodegradable polyesters such as polyglycolic 
acid (PGA), polylactic acid (PLA) and polycaprolactone (PCL). The latter is made of five non-polar 
methylene groups and a relatively polar ester group. This structure implies a very slow degradation 
kinetic compared to those of PLA and PGA that enables PCL to deliver drugs for more than one 
year (11).  
In addition, a scaffold has to display specific mechanical properties, such as elasticity and 
resistance that enable it to tolerate the physiological load over time after implantation (12). The 
ideal scaffold must also display a highly porous structure. Pores interconnection, indeed, is a 
prerequisite for a uniform cell distribution throughout the construct as well as for cell survival, 
proliferation and migration (13).  
Further, these features are the basis for a homogeneous neovascularization of both the 
scaffold and the surrounding tissues after implantation. Scaffold pore size should be at least 100-
200 µm in diameter in order to support an adequate diffusion of oxygen and nutrients as well as 
waste removal (14). 
1.1.4 The angiogenesis cascade   
Angiogenesis, the formation of new blood vessels from existing ones, occurs only during 
post-natal life, both in physiological and pathological conditions, for example wound repair in the 
first case and neoplastic events or inflammation in the second one (16).  
The process is triggered by stimuli related to the secretion of specific growth factors, first of 
all vascular endothelial growth factor (VEGF), but also fibroblast growth factor (FGF) and 
angiopoietin, acting as triggers in response to hypoxia. In hypoxic conditions, indeed, the low 
oxygen level induces the formation of a new vascular network to support cellular metabolism (17). 
Several steps are involved in the process (Figure 2): 1) degradation of the basement membrane by 
proteolytic enzymes secreted by endothelial cells; 2) endothelial cell proliferation; 3) duct formation 
and branching; 4) development of vascular loops; 5) stabilization and functional maturation of 
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newly formed vessels, including the perivascular component and pericytes; 6) synthesis of basal 
membrane constituents (18).  
When oxygen supply to the tissue becomes sufficient, growth factors are down-regulated 
while synthesis and release of angiogenesis inhibitors increase (19). Porous scaffolds generally 
allow the onset of a newly formed vascular network however, this is often composed of irregular 
and tortuous vessels causing a dramatic alteration of blood flow with increased vascular 
permeability and thrombi formation (20).  
In addition, an insufficient vascularization leads to tissue ischemia and, in turn local wounds 
and organ damage (21). Further, the vascularization of an implanted scaffold is often too slow or 
limited to its surface implying scarce nutrients supply followed by implant failure (22). 
 
 
 
Figure 2. Steps involved in the angiogenic process. Hypoxia induces the production of proteases to 
increase the permeability of the capillary vessel wall that allows endothelial cells to migrate, 
proliferate and form tubules. Maturation of the newly formed tubules is associated with an 
increased expression of antiangiogenic factors (Clappat C. et al., Physiol Rev. 2009; 1177-1215). 
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Chapter 2 
 
A bioactive bottom-up scaffold to guide angiogenesis  
 
 
2.1.1 Promoting angiogenesis in tissues engineering 
Theoretically, cells seeded on/onto biomaterials are able to create functional tissues. A 
critical point, however, is how to provide adequate oxygen and nutrients supplies to the inner part of 
the construct in order to support cell survival and proliferation as well as the integration of the 
developing tissue with the host one.  Rapid revascularization of the damaged tissue through the 
implantation of polymeric matrices is essential (23). Polymers used to fabricate scaffolds suitable to 
be invaded by newly formed vessels may be natural or synthetic. Among natural materials 
commonly used there are hyaluronic acid (HA), collagen, fibrin, and alginate that, after 
subcutaneous implantation, may induce a little inflammatory response (24-25-26). Some examples 
of synthetic materials are poly (glycolic acid) (PGA), Poly-L-lactic Acid (PLLA) and copolymers 
such as PLGA. These materials enable the modulation of various parameters, including surface 
features and porosity degree.  
To encourage cell adhesion to biomaterials the tripeptide Arginylglycylaspartic (RGD) 
sequence is commonly used. In fact, RGD-peptide, being a part of fibronectin molecule, mediates 
cell attachment by interacting with cellular integrins. Therefore it is used in the coating of synthetic 
scaffolds for tissue engineering in order to facilitate cell attachment by mimicking physiological 
cues (27).  
Scaffolds alone are able to support vascular infiltration to enhance wound repair while, 
when loaded with growth factors, they can be used for controlled delivery of proangiogenic 
molecules (24). The methods commonly used to load angiogenic factors into the scaffold are: 
adsorption (25), encapsulation (26), entrapment or covalent binding (27). The last three mechanisms 
enable a controlled release of the molecules, however during scaffold manufacturing the bioactivity 
of these molecules may be affected. In order to overcome this issue growth factors may be adsorbed 
on the scaffold surface. Adsorption is achieved by exploiting ionic or hydrogen bonds as well as 
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Van der Waals or hydrophobic forces. These interactions are non-covalent and, in turn, weak 
causing a quick and uncontrolled release of the adsorbent protein.  
Concerning scaffold fabrication techniques over the years two different approaches have 
been developed: top-down or conventional technique and bottom-up or unconventional technique. 
There are several top-down methods that, through a series of chemical reactions or physical 
modifications, lead to the development of a bulk material displaying a given structure with the 
desired characteristics.  
Traditional technologies include solvent casting, gas foaming and phase separation, to name 
a few. The main downside of these techniques is scaffold architecture, which fails to mimic the 
extracellular matrix. In contrast, the bottom-up approach is based on a computer-assisted assembly 
of small blocks, which enables a better control of the polymer matrix structure organization 
 
2.2 Materials and methods 
 
2.2.1 Poly(ε-caprolactone) microsphere production 
PCL microspheres were made by a single oil-in-water emulsion technique. The polymer 
(10% w/v) was dissolved in dichloromethane (DCM Romil Pure Chemicals). An aqueous solution 
of bidistilled water with 0.5% of polyvinyl alcohol (PVA) (100 ml Sigma-Aldrich PVA 4088 MW 
= 13-23 kDa, 87-89% hydrolyzed) and Tween 21 (100 µL) was placed under magnetic stirring at a 
temperature around 100 °C in order to completely dissolve the emulsifying agent (PVA), which is 
essential to reduce coalescence. The polymer solution was added dropwise to the aqueous phase and 
stirred for 3 hours at 500 rpm using a mechanical stirrer.  
Microspheres were then isolated by three washing cycles in distilled water and filtered in 
order to completely remove the PVA (28-29). Afterwards they were sieved with a commercial sieve 
(Sieve IG / 3-EXP) to select microspheres with a 425-500 𝜇m diameter . 
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2.2.2 Fabrication of Poly (lactic-co-glycolic acid) microspheres loaded with QK 
PLGA (Resomer® RG 504H) microspheres containing QK were prepared with the multiple 
emulsion water/oil/water (W/O/W) technique. A sterile water solution containing QK (250 μl) was 
emulsified through homogenization at 8000 rpm for 1 minute in a solution containing 2.5 ml of 
PLGA and poloxamer 188 (ratio 5: 1) in dichloromethane (10% w/v). Poloxamer is a polymer with 
surfactant properties used to protect PLGA microsphere surface during the fabrication process.  
The emulsion obtained was then added to the aqueous solution containing PVA (1.5% w/v) 
(Mowiol® 40-88) and emulsified with an electronic shaker at 450 rpm for 3 hours at room 
temperature, in order to allow solvent evaporation. Afterwards, the microspheres were washed in 30 
ml of distilled water by centrifugation at 5000 rpm for 10 minutes at 4°C (three times) and 
lyophilized through a 24-hour cycle (0.001 atm, -60 °C). 
 
2.2.3 Scaffold assembly 
Scaffolds of 5x5 mm length and 1,5 mm height were assembled by using the sintering 
technique, that allowed a partial dissolution of their surface enabling the creation of three-
dimensional porous structures. During this partial dissolution the microspheres developed the 
connections between each other. For ordered scaffold fabrication microsphere monolayers were 
arranged into a mold of polydimethylsiloxane (PDMS). Afterwards 100 ml of anisole were poured 
over the microspheres in order to induce a moderate swelling and, in turn, the development of 
sintering necks. We chose anisole because this solvent, due to its low toxicity, is considered ideal 
for the fabrication of constructs for in vivo applications (3). After the exposure to anisole for 5-10 
seconds the swelling was stopped and the final structure was fixed by using ethanol then allowed to 
evaporate overnight. 
 
After the creation of the monolayers, another alignment structure (a box shaped 
polytetrafluoroethylene mold), was used to put them in an ordered pile allowing layer sinteringin an 
ordered fashion. This time, the swelling and the neck formation were controlled using a 50/50 
anisole/ethanol solution. In contrast, for randomly assembled scaffold sintering the microspheres 
were poured into the mold and treated with a 50/50 anisole/ethanol solution. 
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A)                  B)  
 
Figure 3. The figure shows the reconstructions made by SkyScan NRecon software of images 
acquired by a micro-CT Scan (Bruker) of orderly (panel A) and randomly (panel B) assembled 
scaffolds.  
 
2.2.4 Scaffold surface treatment 
Surface hydrophobicity greatly enhances the cellular response both in vitro and in vivo (31-
32). However, high hydrophobicity induces a low surface wettability that negatively influences cell 
adhesion and proliferation. Indeed, when a cell suspension is seeded on a PCL surface it is not 
absorbed with a consequent slow cell growth and heterogeneous cell distribution (33).  
Wettability and cell adhesion were improved in both ordered and random scaffolds via 
NaOH treatment by soaking the constructs in 0.1 M NaOH and ethanol (1:1) solution for 15 min at 
37°C (34). This strong alkaline condition improved PCL hydrophilicity through the hydrolysis of 
the ester and the hydroxyl carboxylic acid groups of the polymer. 
 
2.2.5 Water contact angle test 
In order to verify the effect of the NaOH treatment we made the contact angle test. The 
contact angle is the angle formed by the contact of a liquid interface with a solid surface and allows 
to quantify the wettability of the material surface induced by a certain liquid. The measurement was 
performed by placing with a syringe a droplet (~2𝜇L) of deionized water on the sample surface. 
Droplet configuration was then captured with a camera.  
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The value of the contact angle was calculated as the average of the measured left and right 
contact angles formed between the droplet baseline and the tangent at the water/air interface. 
Contact angle measurements were obtained from three different regions of the surface of three 
samples.  
 
2.2.6 Scaffold X-ray microtomography analysis  
A qualitative analysis of scaffold structure was performed using a computerized micro-
tomograph (SkyScan1172, Bruker). Micro-tomography (commonly known as CT scanning) uses X-
rays to obtain projection images of 3D-objects. It quantified pores size and volume as well as the 
total percentage of porosity of the entire matrix.  
To evaluate scaffold porosity, it is necessary to discriminate between the air and the 
absorbent material, corresponding to white and black points respectively. To do this, the software 
(SkyScan NRecon, Bruker) counted the black and white points, obtaining the ratio of the empty 
volume of the object and, in turn, its porosity. 
 
2.2.7 Cell-material interaction 
Human Umbilical Vein Endothelial Cells (HUVEC) (Lonza) were cultured in Human 
Endothelial-SFM Basal medium (Gibco) supplemented with endothelial cell growth factor (100 
mg/ml) (Sigma-Aldrich), 20% foetal bovine serum (Sigma-Aldrich) and 1% Pen Strep (10,000 
U/mL of penicillin G sodium and 10,000 mg/ml streptomycin sulphate in saline 0.85%) (Gibco) at 
37 °C in 5% CO2 and 100% relative humidity until they were confluent. 
Afterwards we detached HUVECs by using trypsin EDTA (Lonza) and counted them. For 
cell adhesion assay we sterilized PCL scaffolds by UV rays before seeding 0.9 × 10
4
cells/scaffold 
(n = 3 each group) in a 96-well plate. After 6 h, cells were detached and counted. To test cell-
material interaction we seeded 2 × 10
4
cells/scaffold in a 96 well plate and incubated them for 48 
hours (n = 4 each group). After 3 days of incubation, scaffolds were fixed with 4% 
paraformaldehyde, washed 3 times with PBS and stained with phalloidin tetramethylrhodamine B 
isothiocyanate (Sigma-Aldrich) and Sytox green (Invitrogen) for actin microfilaments and nuclei, 
respectively.  Cell adhesion and distribution inside the scaffold, were evaluated by a confocal Leica 
SP5 laser scanning microscope, equipped with a water immersion objective HCX IRAPO 25 X 
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0.95. For nuclei detection, samples were excited with a 488 nm argon laser, while for actin we used 
a 543 nm He-Ne laser. Images were processed by a Leica LAS AF software version 2.7.3.9723.  
For scanning electron microscope (SEM) analysis we seeded the scaffolds (n = 3 each 
group) with the same number of cells. After 24 hours we fixed the cellularized constructs in 2.5% 
glutaraldehyde and 0.1 M sodium cacodylate at pH 7.3. Afterwards we washed the samples three 
times for 10 minutes in the same buffer, and then kept them on ice for 1 hour in 1% osmium 
tetroxide and 0.1 M sodium cacodylate at pH 7.3. We then washed the scaffolds again three times 
for 10 minutes in the same buffer and dehydrated them on ice in increasing concentrations of 
ethanol. After dehydration, we moved the samples to the critical point drying (Leica) and placed 
them on an aluminium stub with carbon tape before coating them with 20 nm of gold metal by 
sputter coating (208 HR sputter coater, Cressington). Afterwards, we observed the samples with a 
Zeiss Ultraplus scanning Electron microscope (35). 
 
2.2.8 Gradient generation and sprouting angiogenesis assay 
 In order to study the biological response to the gradient generated by a specific growth 
factor we developed a device equipped with a corridor with a 100µl volume limited by glass walls 
where we positioned on one end the scaffold loaded with QK (40ng) as endothelial growth factor, 
and on the other end three spheroids at a distance of about 1cmeach other (Figure 4).  
Both the scaffold and the spheroids were embedded in a three-dimensional matrix consisting 
of type 1 bovine collagen.  
Depending on spheroid reactivity this method allowed us to assess the diffusion of the 
angiogenic factor in the different areas of the system and, consequently, the capacity of the scaffold 
to generate a spatial gradient.  
After 24 hours, spheroids were fixed with 4% paraformaldehyde, stained with Sytox green 
(Invitrogen) and phalloidin tetramethylrhodamine B isothiocyanate (Sigma-Aldrich) and observed 
by a confocal microscope as described in section 1.3.7. 
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Figure 4. The image shows a petri dish modified according to our experimental setting. We made a 
corridor (red arrows) limited by glass walls where we positioned at the two opposite ends the matrix 
and the spheroids embedded in bovine collagen. 
2.2.9 Scaffold implantation 
Animal experiments were performed in accordance with the Directive 2010/63 / EU. All 
animals were housed in individual cages with free access to food and water. Male Wistar rats 
weighting 250-300g (n=3 each group) were divided into 2 groups and identified as OR and R for 
the recipients of orderly and randomly assembled scaffolds respectively.  
Once anesthetized, the animals were placed in sternal decubitus. After trichotomy and 
disinfection with 10% Iodopovidone  (Betadine®) we performed a horizontal incision of about 1 cm 
centrally and distally to the shoulder blades. We then performed a blunt dissection making a 
subcutaneous pocket of 2-3 cm.  
Once positioned the scaffold inside the pocket, we sutured the skin with a 3/0 silk suture. 
Animals were placed on a thermal bed at 37 °C until their awakening. All the animals received 
antibiotic prophylaxis by enrofloxacin administration in drinking water for 3 days.  
 
2.2.10 Histology and Immunofluorescence analyses  
 
For both histology and immunofluorescence (IF) after euthanasia we harvested the 
integrated scaffolds (n = 3 each group), embedded them in OCT before snap freezingin nitrogen. 
Afterwards samples were cut in slices of 7 µm thickness. For histology the slices were stained with 
Hematoxylin-Eosin (Thermo Scientific ™) and observed by an optic microscope (Olympus BX53) 
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in order to evaluate the integration of the scaffold with the host tissue as well as the eventual 
development of a fibrous capsule around the construct.  
For IF samples were processed for vessel detection and distribution. Slices were stained with 
mouse anti-rat antibodies for CD31 (BD Biosciences) combined with goat anti-mouse fluorescent 
secondary antibody Alexa Fluor 488 (Life Technologies).  
The sections were examined with a fluorescence microscope (Olympus BX53) with an UPL 
SAPO 20 X/0.75 dry objective. The microscope was equipped with a 450-490 nm excitation filter 
and a 500-530 nm emission filter for Alexa Fluor 488. Images were acquired by a digital color 
camera (Olympus DP21) and processed by Image J software. 
 
 
 
2.2.11 Micro-CT analysis 
After euthanasia we infused 100 ml of saline solution in each animal using a syringe pump. 
Immediately after we infused 10 ml of Microfil®, a silicon rubber used as contrast agent for micro-
CT imaging (36). After 24 hours we retrieved the scaffolds integrated with the host tissue. Explants 
were fixed in 10% neutral buffered formalin for at least 24 hours before micro-CT scanning (37).  
 
 
2.3 Results 
2.3.1 NaOH surface treatment improves hydrophilicity 
 
PCL is a highly hydrophobic polymer so it would be naturally inadequate for cell invasion. 
In order to facilitate cell adhesion and proliferation we chemically treated scaffolds with NaOH. We 
then evaluated the efficacy of this treatment by the contact angle test.  
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Conventionally, if water contact angle is < 90° the solid surface is considered hydrophilic 
whereas if it is > 90° the solid surface is considered hydrophobic. We detected contact angle values 
of 104° and 64° in untreated and NaOH treated scaffolds respectively (Figure 5).  
This result supports the hypothesis that NaOH treatment improves scaffolds 
cytocompatibility. 
 
A)                B)  
Figure 5. The figure shows scaffold hydrophilicity evaluated by the water contact angle test: in the 
upper part of each panel it is visible the needle used to generate the droplets. In the lower part of the 
panels the droplets lie on the scaffold surfaces. On the surface of the untreated scaffold (panel A) 
the droplet is not absorbed as it is through the surface of the NaOH treated one (panel B). 
 
2.3.2 Bottom-up approach improves scaffold porosity  
In order to evaluate scaffold porosity, we analysed micro-CT scans by NRecon software. In 
the reconstructed images the black and white points correspond to the void volume and to the 
microspheres respectively (Figure 3). Therefore, by counting the black and white points the 
software provides the data of interest.  
The values resulting from the analysis of our samples showed a porosity of 48% in orderly 
assembled scaffolds versus a porosity of 40% for randomly assembled ones. 
 
2.3.3 Cell adhesion is influenced by surface treatment but not by scaffold architecture 
Cell adhesion and migration throughout the constructs were evaluated both in orderly and 
randomly assembled scaffolds. The cell adhesion assay didn’t reveal any statistical difference 
between the two groups of scaffold (P>0.05), suggesting that the two different manufacturing 
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procedures didn’t influence in vitro biocompatibility (Figure 6). In contrast, scaffold surface 
treatment with NaOH, induced a significant difference in cell behavior (P<0.05) as shown in the 
same Figure, suggesting that the improved surface hydrophilicity promotes cell adhesion.  
 
                                     
 
 
Figure 6. The graph shows the number of HUVEC cells adherent to the scaffolds after 6 hours of 
culture. NaOH treated scaffolds compared to untreated ones show enhanced cell adhesion while no 
difference is induced by the fabrication technique used to produce the orderly and randomly 
assembled constructs; (n = 3) ordered vs random P>0.05; NaOH vs untreated P<0.05. 
 
2.3.4 PCL scaffolds support cell proliferation 
Cell-material interaction between HUVECs and scaffolds was also analysed through 
confocal microscopy, by observing cell morphologyafter staining with Phalloidin 
tetramethylrhodamine and Sytox green chromophores after 3 days of culture. Scaffold surface, as 
well as its cross sections, were covered by HUVECs displaying a well-developed nucleus and 
cytoskeleton (Figure 7).  
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These results support the idea that HUVECs are able to migrate throughout the construct and 
not to just spread on its surface, corroborating the hypothesis that our scaffolds are reliable 
platforms to encourage a homogenous vascularization after implantation. 
 
A)     B)  
Figure 7. Confocal microscopy images of NaOH treated scaffolds acquired 3 days after cell 
seeding. HUVECs were stained with Sytox green and Phalloidin tetramethylrhodamine. The images 
are representative of 3 independent experiments (n = 3 each group) and of 10 acquisitions for each 
scaffold. Microspheres appear uniformly cellularized as well as the entire scaffold surface (panel A, 
scale bar 40 µm) and cross-section (panel B, scale bar 10 µm,25 X magnification). 
 
2.3.5 Growth factor release from the scaffolds are able to develop a biochemical gradient 
 
In order to investigate the ability of the scaffold to induce the development of a biochemical 
gradient we loaded them with QK, a peptide we used as a model molecule, which is able to act as 
endothelial growth factor. To this aim we performed an experiment based on the evaluation of 
sprouting angiogenesis in a 3D collagen matrix containing a QK loaded scaffold. More precisely, 
we looked at sprout formation induced by QK diffusion into the matrix.  
For this purpose we modified a petri dish making a corridor, which allowed us to place both 
the scaffold and the spheroids linearly and to avoid the diffusion of the molecule in all directions. 
After 24 hours of culture we performed a quantitative analysis by counting the average number of 
sprouts developed from each spheroid. Spheroids were divided into 3 groups based on their distance 
from the scaffold.  
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The results showed that the scaffold generates a linear chemical gradient able to stimulate 
spheroid reactivity to an extent that is inversely proportional to the distance, as expected (Figure 8). 
In addition, the difference displayed between the groups C+ and SP1, although it is slight, may 
suggest that a release modulated over time could be powerful even at an early stage (24 hours). 
 
 
 
Figure 8. The graph shows spheroids reaction in response to the stimulation with 40ng/ml of QK 
released by the scaffold over 24 hours of culture. Reactivity was evaluated as the average number of 
sprouts generated from the spheroids. Spheroids belonging to the C+ group were treated with 40 
ng/ml of free QK. Data are shown as mean values ± standard deviation (SD) of 3 independent 
experiments performed in triplicate (p<0.05).  
 
2.3.6 PCL scaffolds are biocompatible 
 
In order to evaluate the safety and the ability of the scaffold to be vascularized and 
integrated into the host tissue we performed a basic histological analysis through hematoxylin and 
eosin staining. The results showed the absence of any adverse reaction at the implantation site 
suggesting that the proposed scaffold is biocompatible (Figure 9).  
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The stained samples, indeed, didn’t display any sign of encapsulation by fibrous tissue at the 
scaffold periphery. 
         
       
Figure 9. Image representative of samples stained by hematoxylin and eosin retrieved 7 days post-
implant (n=3 each group). Scaffolds appear well integrated into the host tissue without any sign of 
encapsulation. 
 
 
2.3.7 Orderly assembled scaffolds are able to modulate angiogenesis  
 
Scaffold vasculogenic potential was evaluated by immunofluorescence staining with anti- 
CD31 antibody. We observed a difference in the extent of vessel penetration into the scaffold with a 
more in depth vessel infiltration in orderly assembled scaffolds versus randomly assembled ones 
(Figure 10). 
These data corroborated the results of micro-CT analysis regarding the different suitability 
of the two groups of constructs to be invaded by the newly formed vessels. 
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             A)              B)  
Figure 10. Images representative of Immunofluorescence staining with anti-CD31 antibody of 
samples retrieved 7 days post-implant (n=3 each group). The images show some vessels branching 
through the pores of the orderly assembled scaffold as indicated by the red arrows (Panel A scale 
bar 500 µm). In contrast, randomly assembled scaffold (Panel B scale bar 500 µm) appears less 
vascularized particularly in its inner part. 
 
2.3.8 Orderly assembled scaffolds display a high degree of vascularization 
The degree and the quality of scaffold vascularization were evaluated by analysing micro-
CT data. All the samples processed were retrieved 7 days after implantation. The degree of 
vascularization was measured throughout the entire scaffold. The volume of the vasculature 
surrounding the retrieved construct was also measured, in order to differentiate the pre-existing 
vasculature at the site of implantation.  
As “surrounding vasculature” we considered the vessels found in a volume of tissue which 
extension was up to 500 microns far from the scaffold surfaces (Figure 11). The total vessel volume 
within the orderly assembled scaffold was greater than the one reported in the randomly assembled 
ones.  
The average percentage of the surrounding vasculature was measured as 1.8 ± 0.52% for 
orderly assembled scaffolds and 0.92% ± 0.79 for randomly assembled ones. In this case the 
statistical analysis performed by using a single factor ANOVA test did not show a significant 
difference between the two groups (n = 3, P-value>0.05), suggesting that the pre-existing 
vasculature at the implantation site did not affect the result.  
Nevertheless, the difference concerning the surrounding vascularization is clear. Further, the 
distribution and the average diameter of the vessels within the scaffold were also evaluated with a 
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CTAn software (SkyScan). In this case, the average value is about 50 µ for both the groups. 
However, the percentage of the vessel number found in the orderly assembled scaffolds is 0.59 % ± 
0.26 versus 0.06 % ± 0.062 of the other group suggesting that porous scaffolds with random 
architecture are less suitable to be invaded by larger vessels. 
 
 
 
Figure 11. Micro-CT images of the newly formed vascular network 7 days after scaffold 
implantation. The images show that vessels mainly run around the construct surfaces in randomly 
assembled scaffold (Panels A, B) compared to the orderly one in which they are distributed more 
homogeneously (Panels C, D). 
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2.4 Conclusions 
 
Establishing an adequate vascularization degree in engineered scaffolds remains a challenge in 
tissue-engineering. Angiogenesis, indeed, is a process of basic importance in many physiological 
processes, leading to the formation of a vascular network able to provide oxygen and nutrients to 
the newly formed tissue.  
A scaffold is a biocompatible structural support, but also a construct potentially able to guide 
regeneration through specific physical and mechanical properties, such as a certain porosity and 
mechanical strength as well as the release of signal molecules. In view of this, the most recent 
scaffold generation includes the ability to control the release of specific growth factors.  
The bottom-up PCL scaffold proposed in this work stems from the rational assembly of single 
units (building blocks). To this purpose we used an assembly procedure based on the solvent 
sintering of microspherical building blocks. The resulting product is a polymer scaffold with 
predefined pore size, high interconnectivity and ability to include growth factors able to control new 
vessel formation.  
The analysis of the biological behaviour of our construct both in vitro and in the preclinical 
setting provides promising results suggesting its potential use for tissue regeneration. The data 
presented in the previous sections encourage us to complete the study by assaying the ability of the 
QK loaded scaffold to guide neovascularization after implantation. However, before starting with a 
new preclinical trial we plan to complete a full characterization of the release properties of our 
product. 
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Chapter 3 
 
 
Modulation of topographical signals to guide directional 
sprouting  
 
 
3.1 Introduction  
 
3.1.1 Biochemical and biomechanical cues 
Angiogenesis is a process that requires the coordination of different cellular events 
originating from different signals such as hypoxia and inflammation (1).  Endothelial cells (ECs) 
are particularly influenced by signals coming from the extracellular matrix (ECM) and from the 
basal membrane, which are both rich in topographical cues (2). These signals start a cascade of 
events promoting different cellular processes like migration, proliferation, tubulogenesis and 
phenotype determination. All these events are related to the interaction between the integrins, which 
are proteins situated on the outer surface of the cell membrane, and the ECM ligands such as 
fibronectin and laminin (Figure. 1).  
In some pathological conditions, this sequence of events can be altered or absent. In 
addition, revascularization is often too slow or limited to the surface layers, resulting in inadequate 
supply of O2 and nutrients (3). In this context, all these aspects are of basic importance to create 
tissue engineered constructs able to resemble the natural characteristics of the ECM (4).  
Biomaterials used as three-dimensional matrices for the cells are named “scaffolds”. 
Therefore, a scaffold represents the extracellular environment that supports cell growth, 
proliferation and differentiation during tissue and organ regeneration. In addition, it temporarily 
replaces the mechanical function of the natural ECM, gradually degrading in order to be replaced by 
the newly synthesized one.  
37 
 
Properly designed porous scaffolds are able to encourage the formation of a functional 
vascular network, however the newly formed vessels are generally irregular and tortuous. This 
irregularity provokes blood flow alterations with the consequent increase of vascular permeability 
and blood clot formation. For this reasons the spatial and temporal control over the network 
formation remains an open challenge in this field, being the generation of a functional vasculature 
essential for the development of well-organized tissues (5).  
Therefore, tissue engineering currently aims to the dynamic control of vascular network 
formation through the use of new materials and the set-up of new strategies. Contact guidance is the 
process through which cells respond to the specific structural arrangement of the surrounding 
microenvironment, modifying their shape but also their migration direction according to it (6). 
 
 
            
Figure 1. The image depicts the complexity of the signals involved in the cell-matrix interplay. 
Biochemical and biomechanical stimuli derived from the ECM trigger intracellular signals through 
multiple pathways. These signals are also able to direct cell differentiation and, therefore, to 
influence cell phenotype (Thannickal V.J. et al. Am J Pathol 2014, 184: 1643e1651). 
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3.1.2 Topographic signal influences cell behaviour 
The cell-substrate interplay is critical in several cellular mechanisms. Singhvi et al. 
demonstrated the influence of topographical signals on endothelial cell behaviour through the use of 
patterned substrates, that are able to mimic the topographic features of the ECM (6). An intrinsic 
property of ECs is their capacity to exert mechanical forces on the external environment. These 
forces can modify the mechanical and structural features of the matrix that, in turn, activates 
feedback responses able to regulate the different cell functions. Collagen and fibrin, indeed, are 
often used to induce network formation in vitro. In fact, as reported by Lesman and colleagues they 
both form fibrillar interconnected structures that can be highly remodelled also showing unique 
physical properties (7).  
These tubules follow the direction of collagen fibers that have previously been aligned by 
EC traction forces. Further, when external forces elongate this fibrillar gel, tubules alignment 
follows the same direction, suggesting that the forces induced by vessel formation are sufficient to 
cause a far-reaching deformation inside the gel (8). Therefore, it seems clear how cells 
communicate through the substrate deformation caused by cell traction forces.  
Several studies show that the mechanical stiffness of the environment directly influences the 
formation of tubule-like structures in both 2D and 3D cultures based on fibrin and collagen gels (8). 
Deroanne and co-workers showed, for example, that the different degree of collagen stiffness 
results in morphology and phenotype modifications revealing that rigid structures discourage tubule 
formation (6). 
 
 
3.1.3 Sprout formation during angiogenesis 
As described in Chapter 1, tubulogenesis requires the coordination of many events involving 
cytoskelethon, actin, microtubules, and integrins, which expression is regulated by the rigidity of 
the ECM. Shen at al. revealed that the reduced adhesion between ECs and the extracellular matrix 
improves vascular network organization. In addition, Fisher et al. showed that myosin II inhibits 
blood vessels branching, so that its local diminution increases sprout formation.  
Over the past few years several models based on cells combined with biomaterials allowed 
the study of vessel branching mechanisms in vitro. De Mel et al., indeed, showed that the 
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application of mechanical forces to the cells as well as the control of their internal tension 
influences tubule organization and orientation (9). However, a more in-depth comprehension of the 
mechanisms that underlie these phenomena is mandatory to support the generation of a clinically 
relevant vascular network (7). 
 
3.1.4 How a pattern can influence cell behaviour 
Once explained the impact of the microenvironment on cell function, in order to support and 
direct cell growth it has to be understood how the 3D structure of a biomaterial should be and how 
its modification may influence cell behaviour. To this purpose different protocols have been 
developed over the past decade. The majority of them are based on the contact guidance of the 3D 
matrix, but none of them is able to recapitulate the dynamic behaviour of the natural ECM (9).  
Among the in vitro models, we chose a sprouting angiogenesis assay based on the use of 
spheroids made of human umbilical vein endothelial cells (HUVECs). This assay, indeed, holds the 
following advantages: 
• is relatively fast and widely accepted   
• mimics the physiological processes better than a standard 2D culture 
• shows the different cellular properties (adhesion, proliferation, migration) involved in the 
process 
• allows the observation of both spheroid core and branching tubules (10). 
In our work, we first analysed sprouting angiogenesis in a “semi-3D” environment 
represented by a bottom-patterned cell culture plate. We defined this environment as “semi-3D” 
because collagen does not embed the spheroids but just covers them. Contemporarily, in order to 
understand the role of the dynamical change of the topographical signal in the early-stage of 
sprouting angiogenesis we chose a 2D platform made up of a photosensitive polymer, named poly 
(Disperse Red 1 methacrylate). This polymer, composed of azobenzenes, is able to modify its 
surface shape following the application of a light stimulus (11).  
Azobenzenes are molecules able to absorb light at a specific wavelength (514 nm in our 
case) and to modify their geometry through trans-cis-trans isomerization. This feature can be 
exploited to draw a variety of patterns through the exposure of the polymer to a laser beam of a 
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confocal microscope. This method, that may be defined “single-laser-beam technique”, allows a 
real-time patterning together with the imaging of the consequent cell behaviour (12).  
 
3.2 Materials and methods 
 
3.2.1 Writable single-well system 
Commercial poly (Disperse Red 1 methacrylate) (pDR1m) (Sigma-Aldrich) was dissolved 
in chloroform (5% w/v) and then deposed onto a glass coverslip (15 mm diameter) through spin 
coating technique. A custom-made well plate system with azopolymers at the bottom of each well 
was built. A polystyrene empty cylinder of 10 mm internal diameter was glued on each well with a 
UV-based polyurethane polymer membrane, named Norland optical adhesive (NOA63) (Figure2). 
NOA is a light-cured polymer that is widely used in soft lithography and in many other laboratory 
practices 
 
A)    B)    C)  
Figure 2. The image shows how we prepared the single-well custom-made system. Firstly, we 
glued a glass slide coated with the polymer (panel A) on the perforated bottom of a p35 petri dish 
(panel B). Secondarily we made the walls of the well by gluing on the bottom of the petri dish the 
walls of a standard 48 well cell culture plate (panel C). 
 
3.2.2 NOA pre-patterned single-well system 
Pre-patterned single wells were produced using NOA. A NOA patterned substrate is 
obtained by UV polymerization of a NOA coated surface enlightened at 365 nm wavelength for 20 
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minutes. After that, the patterned substrate is glued to the bottom of the well as previously 
described. 
 
3.2.3 Cell culture and generation of endothelial spheroids 
Human Umbilical Vein Endothelial Cells (HUVECs) (Lonza) were grown in Medium 200 
supplemented with LSGS kit (Life-Technologies) at 37 °C in 5% CO2 and 100% relative humidity. 
Cells were seeded into tissue culture flasks and cultured until they reached confluence. To generate 
endothelial spheroids, they were used at early passages (II-IV).  
After 3-4 days of culture, confluent HUVEC monolayers were trypsinized and 800 
cells/spheroid were suspended in culture medium containing 0.25 (w/v) carboxymethylcellulose 
(Sigma), seeded into ultra-low-attachment u-bottom 96-well plates (Costar) and cultured to allow 
spheroid formation (13). 
 
3.2.4 Sprouting angiogenesis assay on patterned surfaces 
After 24h of culture, spheroids were harvested and centrifuged at 900 rpm for 15 min. Then, 
1-2 spheroids each time were seeded on a polymer coated glass slide (single-well system). 
Afterwards, they were covered with 1.2 mg/ml of bovine skin collagen. After collagen 
polymerization, M200 culture medium, supplemented with LSGS kit (Life-Technologies) and 
Hepes 25 µl/ml (Sigma) was added into the single-well system.  
Polymer surface was then photo-patterned by using a Leica SP5 confocal microscope with 
an Argon laser set at 514 nm wavelength. Rectangular regions of interests (ROI) have been drawn, 
with a spacing of 2 µm, directly underneath each spheroid (14). Spheroids belonging to the control 
group were seeded in the same conditions on a glass slide without the polymer. Samples, prepared 
in triplicates, were left in the incubator overnight and imaged by an inverted microscope the day 
after.  
Spheroids were then fixed in 4% paraformaldehyde (PFA) and stained for imaging with 
Sytox green (Invitrogen) and phalloidin tetramethylrhodamine B isothiocyanate (Sigma-Aldrich) in 
order to be observed by a Leica SP5 confocal laser scanning microscope, equipped with a water 
immersion objective. For the study that included static patterned surfaces both spheroids and 
collagen fibers were imaged through a multiphoton microscope (TCP SP5 multiphoton, Leica 
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Microsystems). Collagen images were acquired by using the second harmonic generation (SHG) 
technique. 
 
 
3.2.5 Pattern writing simulation 
In order to ascertain that was not the laser that influenced sprout orientation, the spheroids were 
seeded in standard conditions in a common well-plate or on a bare glass. After collagen 
polymerization, we simulated the pattern writing as previously described. Afterwards, spheroids 
were incubated overnight. 
 
3.3 Results 
 
3.3.1 Surfaces patterned by single-laser-beam technique influence sprout orientation 
The evaluation of sprouting orientation made by confocal microscope showed that sprouts 
were mostly aligned along the pattern direction, while the spheroid cores acquired a polarized shape 
(Figure 3). On the contrary, when cultured in standard conditions in a common plate or on a bare 
glass, spheroids developed isotropic tubules, while their cores maintained a rounded morphology. 
Moreover, we noticed a high remodelling of the collagen along the axis of the patterned matrix 
around both the spheroid cores and ramifications, suggesting that cell activity in those regions was 
intense.  
To check whether the material was really influencing sprouting, we performed a time-lapse 
imaging using a confocal microscope after pattern inscription. These videos showed an increased 
cell activity after patterning, with the following change of sprout direction (Figure 4). 
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A)        B)  
Figure 3. Confocal microscopy images of HUVEC spheroids acquired 24h after seeding. Spheroids 
were stained with Sytox green and Phalloidin. Images are representative of 3 independent 
experiments performed in triplicate. Panel (A shows sprout development following the direction of 
the pattern (blue arrow), in contrast with the isotropic tubules developed by the spheroids of the 
control group (Panel B). 
 
          A)                   B)    
Figure 4. Images taken from a time lapse video of a HUVEC spheroid seeded on pDR1m polymer. 
Panel A) corresponds to a spheroid imaged right after pattern inscription, while panel B) 
corresponds to the same spheroid imaged 132 minutes later. Red arrows indicate pattern direction, 
while blue arrows indicate the modified position of the sprout in response to the pattern. 
 
3.3.2 Effect of static patterns on sprout alignment  
Lin et al. support the hypothesis that fibrillar matrices such as collagen or fibrin gels 
influence cell orientation. To exclude the possibility that sprouts followed the signal from the 
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fibrillar matrix and not the one from the inscribed pattern, we observed collagen organization by 
second harmonic generation (SHG) imaging technique using a multiphoton microscope.  
For this study, we designed a static pattern with a specific material, the Norland optical 
adhesive (NOA). When we tested spheroid behaviour on a NOA pre-patterned surface we saw that 
even in this case, as happened when the pattern was written after spheroid seeding, the sprouts 
elongated in the pattern direction.  
Furthermore, we noticed that collagen remodelling made by the sprouts is more intense 
around them (Figure 5) supporting our hypothesis that is the pattern and not the collagen fibers 
laying on the pre-patterned polymer to influence sprout direction.   
 
 
 
Figure 5. Multiphoton microscopy images of HUVEC spheroids acquired 24h after the seeding on 
a NOA static pattern. As shown in panel (A both the spheroid core and the sprouts are elongated 
following the direction of the pattern. Panel B) displays collagen organization remodelled by the 
sprouts imaged by second harmonic generation technique. In both panels the blue arrow indicates 
the direction of the pattern. 
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3.3.3 Laser illumination does not influence spheroid behaviour 
To assess whether the laser light affects sprouts directional orientation, we simulated the 
pattern inscription by pointing the laser on the standard plate that contained the spheroids exactly as 
we did when we draw the pattern underneath them.  
The images acquired by a confocal microscope show that 24 hours after illumination with 
the single-laser-beam technique spheroids developed isotropic sprouts, while their cores maintained 
a rounded morphology (Figure 5). This finding allowed us to exclude a direct role of laser 
illumination in the development of aligned sprouts.  
 
 
  
Figure 6. Confocal microscopy image representative of spheroid behaviour 24h afterillumination 
with a single-laser-beam. Spheroids were stained with Sytox green and Phalloidin. The picture 
shows that there is no influence of laser illumination on sprout orientation. 
 
3.4 Conclusions 
Understanding cell behaviour in response to external environmental stimuli is central to 
tissue engineering. Nowadays, an increasing number of studies investigate cell aptitude in following 
the physical characteristics, in particular topography, of the culture substrate.  
This concept becomes critical when extended to cells as functional units of tissues and 
organs, switching from the culture plate to the body. In this work we looked at the influence of 
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dynamic topographic signals on sprouting angiogenesis but also at the possibility to exert a 
potential space-time control.  
To test our hypothesis, we performed an angiogenesis assay based on the use of spheroids 
composed of human vein endothelial umbilical cells. We made the topographic signal by using poly 
(Disperse Red 1 methacrylate) (pDR1m), that is a polymer able to change its surface profile when 
illuminated.  
We showed that the topographic signal we can write on the polymer surface is able to 
influence cell behaviour. In particular, we observed that spheroid sprouts were mostly aligned along 
the pattern direction, while their cores acquired a polarized shape. In contrast, spheroids belonging 
to the control group developed isotropic tubules with the cores featured by a standard rounded 
morphology.  
Collectively, these data support our hypothesis that the platform we developed may be used 
as a reliable tool to investigate what physiologically happens to the cells when their 
microenvironment undergoes dynamic topographic modifications. 
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Chapter 4 
 
 
Controlled delivery of Carbon Monoxide from PLGA 
nanoparticles for liver regeneration 
 
 
 
 
 
4.1 Introduction  
  
4.1.1 Liver regenerative ability   
The liver performs many physiological key functions such as to defend the body against 
toxic chemicals absorbed through foods; to secrete essential proteins, for example albumin and the 
majority of coagulation factors; to storage glycogen, which is an important energy reserve and to 
regulate the levels of ammonia enabling the brain function (1). Last but not least, liver is able to 
return to its original mass after a resection or an injury thanks to its ability to regenerate (1). 
  In case of partial hepatectomy (PHTx) hepatocyte mitosis begins within 24-48 hours after 
the end of the surgical procedure. Afterwards, the remnant liver becomes hypertrophic in order 
to compensate the removed volume and the impaired organ function (2). Liver resection is rarely 
performed in patients with liver cirrhosis, in fact it is known that in this case liver regeneration is 
severely compromised. There is extensive literature on liver regeneration after PHx in “normal” 
liver, while fibrotic organ regeneration remains understudied (2).  
Transplantation is often the only treatment available, however it is limited by the shortage of 
organ donors and by the potential post-operative liver failure (3). Alternatives to liver 
transplantation have been studied but they cannot be applied to the clinical practice due to several 
hindrances. In fact, decellularized scaffolds can be damaged by the reagents used during the 
procedure while polymer scaffolds and extracorporeal bioartificial liver fail to provide sufficient 
nutrients and O2 supplies (4). Although the widespread interest in the field, effective therapies to 
promote the regeneration of a damaged liver have not been found yet (5).  
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In view of these considerations, preclinical studies focused on the development of new 
approaches for liver regeneration are crucial. The most commonly used experimental model of 
liver injury is the partial hepatectomy (PHx). After PHx, up to 95% of the hepatocytes start to 
replicate in order to compensate the activity of the lost tissue; the residual liver increases its 
volume until the original liver mass has been replaced (2).  
  
 
4.1.3 CO-releasing molecules 
 
The literature reports CO ability to stimulate cell replication and, therefore, to modulate hepatocyte 
(HCs) proliferation during regeneration (3).  
CO use in the clinic, however, still suffers from several unsolved issues such as the difficulties 
related to its dosage when administered by inhalation together with the inadequate local delivery, 
low bioavailability and poor water solubility (6-7). 
In view of the above-mentioned features of CO there is a growing interest in the 
development of molecules able to release it in a controlled fashion. In this perspective the potential 
of the so-called CO-releasing molecules (CORMs), discovered by Motterlini et al. is huge (8). 
These compounds are generally transition metal carbonyls that display the same pharmacological 
activity of the gas, including vessel relaxation, attenuation of coronary vasoconstriction and 
suppression of acute hypertension. However, their use in the clinical practice is hampered by some 
intrinsic characteristics. For example, CORM-1 (dimanganese decacarbonyl) and CORM-2 
(tricarbonyldichlororuthenium(II)) besides the inclusion of transition metals in their molecules are 
soluble only in organic solvents and release CO very quickly (few minutes). In contrast, CORM-3 
(Tricarbonylchloro (glycinato) ruthenium(II)) is soluble in water but it still releases CO too fast. 
Further, CORM-A1 (sodium boranocarbonate) does not contains metals, is soluble in water and 
releases CO slower than the other CORMS but, as shown in Figure 2, still too rapidly (9).  
In this scenario the goal of our work is the maintenance of therapeutic levels of CO in the 
blood through a controlled release of CORMs from engineered nanoparticles. 
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Figure 2. The graph shows the release curves of CO from CORM-A1. Release kinetics were made 
using the conversion rate of myoglobin (Mb) into deoxy-myoglobin (MbCO). CO binding to Mb 
was monitored over time by measuring the changes in the absorption spectra (Motterlini et al., 
FASEB J 10.1096/fj.04-2169fje). 
 
 
4.1.4 Poly (lactic-co-glycolic acid) is a good candidate for nanoparticle fabrication 
  
In general CO intracellular delivery from CORMs is difficult due to the low solubility and 
cellular uptake of these molecules. Many research groups are currently involved in the development 
of the ideal carrier for CORMs transport and release.  
We chose the FDA-approved polymer poly (lactic-co-glycolic acid) (PLGA) to fabricate our 
nanoparticles (NPs). PLGA is widely used thanks to the possibility to control the release kinetic of 
any encapsulated molecule by playing with its degradation time.  
In addition, varying the molecular weight of the polymer and modifying the ratio between poly-
lactic acid and glycolic acid, one can modulate PLGA physical properties and degradation kinetics. 
In particular, PLGA degradation rate can be accelerated by increasing its hydrophilicity which is 
generally required when a short-term release (up to 1 month) is desirable. For a long-term release 
(1-6 months), it is more appropriate to consider the choice of a polymer with low hydrophilicity.  
Furthermore, PLGA is featured by a high versatility since it can be used to fabricate micro 
and nano-carriers as well as prosthesis with a thickness of some millimeters. These carriers are able 
to vehiculate a wide range of molecules such as drugs, peptides or proteins (Figure 3). 
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Figure 3. In vivo degradation profiles for 50:50, 65:35, 75:25 and 85:15 of the poly (lactic-co-
glycolic acid) (PLGA) . Note that 65:35 PLGA means that the 65% of the copolymer is lactic acid 
and the 35% is glycolic acid. (Makadia et al.; Polymers 2011; 3(3): 1377–1397). 
 
4.2 Materials and methods  
 
  
4.2.1 Hepatic resection model (70%) 
According to approved institutional animal care and use committee (IACUC) protocols we 
used male CD-1 mice of 6-8 weeks of age, weighing 25-35 gr to reproduce a 70% hepatectomy 
model. Animals were anesthetized with isoflurane, after skin sanitization we made a blunt 
dissection of the abdominal skin and muscles and then an incision to expose the liver. Afterwards 
we placed and tied a 2-0 non absorbable suture as closest as possible to the base of the left lateral 
lobe of the liver (Figure 4). we then resected the liver 2-3 mm away from the knot. The same 
procedure was repeated for both the right lateral and the median lobes. We then sutured the 
peritoneum and the skin with a 4-0 Vicryl absorbable suture (10). 
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Figure 4. The figure shows how to place the ligatures for an optimal ligation of the three lobes of 
the liver that have to be removed for a 70% liver resection (Y.A. Nevzorova et al., J Lab Anim 2015; 
49(S1) 81–88). 
 
4.2.2 Production of poly (lactic-co-glycolic acid) nanoparticles  
Poly lactic-co-glycolic acid (PLGA) (Resomer RG 504H, Evonik, Germany) nanoparticles 
were prepared according to the double nanoemulsion technique (11). Briefly, 20 mg of PLGA 
(75:25) were dissolved in ethyl acetate (EA) and 100 µl of a solution of rohodamine 6G (Sigma-
Aldrich) in water (1mg/ml) were added. The latter mixture was emulsified by vortexing for 5 
minutes.  
The resulting emulsion was then sonicated using a probe sonifier (Qsonica) for 30 sec at 
amplitude 2 (primary nanoemulsion). This primary nanoemulsion was immediately poured into 3 
ml of 1% (w/v) aqueous Pluronic F68 (Sigma-Aldrich), and then sonicated for 120 sec at 
Amplitude 1 (secondary nanoemulsion). The resulted double nanoemulsion was then poured into 7 
ml of water and stirred overnight to allow the evaporation of the organic phase.  
Finally, nanoparticles were washed and collected using Amicon ultra-4 centrifuge tubes (10 
kDa, Millipore) (15’ 4°C 5000 rpm). NPs were then filtered using 0.22 µm filters. 
 
4.2.3 Cryo-TEM analysis of PLGA nanoparticles 
Nanoparticle morphology was observed by cryo-TEM (transmission electron microscope). 
In particular, frozen hydrated samples were prepared by applying a 3 μl aliquot to a previously 
glow-discharged 200 mesh holey carbon grid (Ted Pella, USA). Before plunging into nitrogen 
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cooled liquid propane, the grid was blotted for 1.5 sec in a chamber at a temperature of 4 °C and a 
humidity of 90% using a FEI Vitrobot Mark IV (FEI company, the Netherlands).  
The particles were imaged using a Tecnai G2 F20 transmission electron microscope (FEI 
company, the Netherland) equipped with a Shotky field emission gun operating at an acceleration 
voltage of 200 kV and recorded at low dose with a 2k x 2k Ultrascan  CCD camera (Gatan, USA). 
 
4.2.4 Nanoparticle characterization 
 We made a qualitative evaluation of NP size distribution and polydispersity index (PDI) 
by dynamic light scattering (DLS). During DLS analysis a laser illuminates the sample and the 
intensity of the scattered light variation is measured. NP movement generates the intensity variation 
measured by the detector.  
 The size of our NPs was <100 nm and the PDI was 0.164; the graph also shows that 
nanoparticles were well dispersed as demonstrated by the single peak of the curve <100 nm (Figure 
5). NP morphology was assessed by cryogenic transmission electron microscopy (cryo-TEM) that is 
the technique generally used to study size, shape and internal structure of nanoparticulate carrier 
systems (Figure 6). 
 
    
 
 
 
Figure 5. The graph displays the sizes range of PLGA nanoparticles measured with dynamic 
light scattering. The single peak of the curve shows that nanoparticles are well dispersed.  
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Figure 6. The picture shows a cryogenic transmission electron microscopy image of PLGA 
nanoparticles (NPs). The NPs displayed are intact and homogeneously rounded. 
 
4.2.5 Nanoparticle infusion into the portal vein 
 To infuse the NPs into the portal vein mice were anesthetized with isoflurane. After skin 
sanitization we did a blunt dissection and then an incision of skin and abdominal muscles, 
afterwards we identified and exposed the portal vein. Briefly a dose of 15mg/kg of NPs suspended 
in a volume of 100 µl was infused into the vein with a 1ml syringe (12). At the end of the infusion 
the discontinued tissues were sutured with a Vicryl 4/0 absorbable suture.  
 
 
4.3 Results 
 
4.3.1 PLGA nanoparticles fabricated with the double emulsion technique are safe 
 Before loading the NPs with CORMs we tested their safety by administering them through 
the portal vein. We then evaluated liver reaction by measuring ALT levels in the blood at different 
time points (1 hour, 3 and 7 days).  
 When measured 1 hour after the infusion, ALT were higher in treated mice than in the 
untreated ones, probably because of the transient injury induced by the increased pressure into the 
portal vein during the infusion.  
 After 3 days, indeed, the value returned to the baseline and so was maintained until the 
last endpoint. This result guarantees that our PLGA nanoparticles fabricated by using the double 
emulsion technique can be safely administered by intraportal infusion (Figure 7). 
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Figure 7.  Blood levels of ALT measured 1 hour and 3 and 7 days after nanoparticle administration. 
The graph shows that the infusion of PLGA nanoparticles through the portal vein do not damage the 
organ.  
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4.4 Conclusions 
 Several studies revealed the positive effects of CO in the restoration of organ functions 
(liver, kidney, heart and others) after injury, however this molecule is still considered mostly a toxic 
gas.  
 In addition, CO therapeutic use is hampered by the difficulty to modulate its 
administration. CO, indeed, is slightly soluble in water so that to reach therapeutic concentrations it 
should be inhaled at high doses becoming, therefore, dangerous. 
 These issues have been partially overcome through the introduction of the so-called CO-
releasing molecules (CORMs). These compounds are able to release CO in the blood, nevertheless, 
the release of the gas is still too fast for therapeutic applications.  
 In this context we are testing the hypothesis that by encapsulating CORMs in polymer 
nanoparticles we will be able to vehiculate and release them, and in turn CO, in a controlled 
manner. We chose a model of liver regeneration because of our past experience with studies 
focused on the investigation of the regenerative ability of CO after liver ischemia/reperfusion injury 
(13).  
 The data presented in this chapter, although very partial, encourage us to test the ability of 
CORM loaded nanoparticles to enhance liver regeneration. 
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